BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 8780460)

  • 1. Neutralization of bee venom lethality by immune serum antibodies.
    Schumacher MJ; Egen NB; Tanner D
    Am J Trop Med Hyg; 1996 Aug; 55(2):197-201. PubMed ID: 8780460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel Fab-based antivenom for the treatment of mass bee attacks.
    Jones RG; Corteling RL; Bhogal G; Landon J
    Am J Trop Med Hyg; 1999 Sep; 61(3):361-6. PubMed ID: 10497971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Production of human antibody fragments binding to melittin and phospholipase A2 in Africanised bee venom: minimising venom toxicity.
    Funayama JC; Pucca MB; Roncolato EC; Bertolini TB; Campos LB; Barbosa JE
    Basic Clin Pharmacol Toxicol; 2012 Mar; 110(3):290-7. PubMed ID: 22017759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantity, analysis, and lethality of European and Africanized honey bee venoms.
    Schumacher MJ; Schmidt JO; Egen NB; Lowry JE
    Am J Trop Med Hyg; 1990 Jul; 43(1):79-86. PubMed ID: 2200291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibodies to purified bee venom proteins and peptides. I. Development of a highly specific RAST for bee venom antigens and its application to bee sting allergy.
    Kemeny DM; Harries MG; Youlten LJ; Mackenzie-Mills M; Lessof MH
    J Allergy Clin Immunol; 1983 May; 71(5):505-14. PubMed ID: 6601672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human scFv antibodies (Afribumabs) against Africanized bee venom: Advances in melittin recognition.
    Pessenda G; Silva LC; Campos LB; Pacello EM; Pucca MB; Martinez EZ; Barbosa JE
    Toxicon; 2016 Mar; 112():59-67. PubMed ID: 26829652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibodies to purified bee venom proteins and peptides. II. A detailed study of changes in IgE and IgG antibodies to individual bee venom antigens.
    Kemeny DM; MacKenzie-Mills M; Harries MG; Youlten LJ; Lessof MH
    J Allergy Clin Immunol; 1983 Oct; 72(4):376-85. PubMed ID: 6619452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo neutralization of bee venom lethality by IgY antibodies.
    Leiva CL; Geoghegan P; Lammer M; Cangelosi A; Mariconda V; Celi AB; Brero ML; Chacana P
    Mol Immunol; 2021 Jul; 135():183-190. PubMed ID: 33930713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunological studies on bee-keepers: specific IgG and subclass typing IgG against bee venom and bee venom components.
    Urbanek R; Forster J; Ziupa J; Karitzky D
    Klin Wochenschr; 1980 Nov; 58(22):1257-60. PubMed ID: 7464005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sub-class of IgG anti-bee venom antibody produced during bee venom immunotherapy and its relationship to long-term protection from bee stings and following termination of venom immunotherapy.
    Urbanek R; Kemeny DM; Richards D
    Clin Allergy; 1986 Jul; 16(4):317-22. PubMed ID: 3742787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IgE antibodies to bee venom, phospholipase A, melittin and wasp venom.
    Jarisch R; Yman L; Boltz A; Sandor I; Janitsch A
    Clin Allergy; 1979 Sep; 9(5):535-41. PubMed ID: 498494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Novel Apilic Antivenom to Treat Massive, Africanized Honeybee Attacks: A Preclinical Study from the Lethality to Some Biochemical and Pharmacological Activities Neutralization.
    Teixeira-Cruz JM; Strauch MA; Monteiro-Machado M; Tavares-Henriques MS; de Moraes JA; Ribeiro da Cunha LE; Ferreira RS; Barraviera B; Quintas LEM; Melo PA
    Toxins (Basel); 2021 Jan; 13(1):. PubMed ID: 33466223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and immunological studies of beekeepers.
    Light WC; Reisman RE; Wypych JI; Arbesman CE
    Clin Allergy; 1975 Dec; 5(4):389-95. PubMed ID: 1053439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in the levels of anti-phospholipase A2 and hyaluronidase antibodies during bee venom immunotherapy.
    Kemeny DM; McKenzie-Mills M; Harries MG; Youlten LJ; Lessof MH
    Monogr Allergy; 1983; 18():150-2. PubMed ID: 6646134
    [No Abstract]   [Full Text] [Related]  

  • 15. Serial studies on the functional affinity and heterogeneity of antibodies of different IgG subclasses to phospholipase A2 produced in response to bee-venom immunotherapy.
    Devey ME; Lee SR; Richards D; Kemeny DM
    J Allergy Clin Immunol; 1989 Sep; 84(3):326-30. PubMed ID: 2778238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rabbit IgG antibodies against phospholipase A2 from Crotalus durissus terrificus neutralize the lethal activity of the venom.
    Rodriguez JP; De Marzi M; Maruñak S; Malchiodi EL; Leiva LC; Acosta O
    Medicina (B Aires); 2006; 66(6):512-6. PubMed ID: 17240621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enzyme-like immunosorbent assay (ELISA) for immunoglobulin G antibodies against insect venoms.
    Grant JA; Goldblum RM; Rahr R; Thueson DO; Farnam J; Gillaspy J
    J Allergy Clin Immunol; 1981 Aug; 68(2):112-8. PubMed ID: 6166648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enzyme-linked immunosorbent assay of allergen-specific IgG antibodies in bee sting allergic patients hyposensitized with pure bee venom.
    Forster J; Urbanek R
    Klin Wochenschr; 1979 Apr; 57(8):421-2. PubMed ID: 459376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantification of IgG and IgG4 antibodies to bee venom phospholipase A2 by competitive inhibition in ELISA.
    Rieben R; Blaser K
    J Immunol Methods; 1989 Apr; 119(1):1-8. PubMed ID: 2708823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Assessment of hypersensitivity to honey-bee venom in beekeepers by skin tests].
    Becerril-Ángeles M; Núñez-Velázquez M; Marín-Martínez J;
    Rev Alerg Mex; 2013; 60(4):164-7. PubMed ID: 24912908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.